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Wavelength Optimization for Quantitative Spectral
Imaging of Breast Tumor Margins
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Abstract
A wavelength selection method that combines an inverse Monte Carlo model of reflectance and a genetic algorithm for
global optimization was developed for the application of spectral imaging of breast tumor margins. The selection of
wavelengths impacts system design in cost, size, and accuracy of tissue quantitation. The minimum number of wavelengths
required for the accurate quantitation of tissue optical properties is 8, with diminishing gains for additional wavelengths.
The resulting wavelength choices for the specific probe geometry used for the breast tumor margin spectral imaging
application were tested in an independent pathology-confirmed ex vivo breast tissue data set and in tissue-mimicking
phantoms. In breast tissue, the optical endpoints (hemoglobin, b-carotene, and scattering) that provide the contrast
between normal and malignant tissue specimens are extracted with the optimized 8-wavelength set with ,9% error
compared to the full spectrum (450–600 nm). A multi-absorber liquid phantom study was also performed to show the
improved extraction accuracy with optimization and without optimization. This technique for selecting wavelengths can be
used for designing spectral imaging systems for other clinical applications.
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a broadband illumination source, an 8-channel fiber optic conduit
to direct light to and from the tissue, and an imaging spectrograph
and cooled CCD for detection. Each placement of the imaging
probe allowed for diffuse reflectance spectra (450–600 nm) to be
measured from up to 8 sites on the margin. Multiple placements of
the probe allowed for mapping the entire margin surface. Optical
properties of the specimens were extracted to create tissue
composition maps of total hemoglobin concentration, b-carotene
concentration, and tissue scattering using a fast, scalable Monte
Carlo model of reflectance previously developed by our group
[5,6]. Pathologically-confirmed positive margins, showed significantly lower b-carotene/scattering ratios compared to negative
margins. This finding reflects a decrease in fat content and an
increase in fibroglandular content associated with margin positivity. The sensitivity and specificity of the system for determining
margin status was 79% and 67%, respectively [7].
The clinical adaptability of this technology will be impacted by
its size, cost, and the time needed to diagnostically map tumor
margins. This motivated the design of a compact and cost-effective
device based on the utilization of a few discrete wavelengths for
illumination to replace a broadband source and monochromator
in the original system and inexpensive photodiode arrays for
detection in lieu of a spectrograph and CCD camera [8–10].

Introduction
A wavelength optimization strategy is developed to improve the
design of a novel spectral imaging probe array [1] for quantitative
assessment of breast tissue margins during partial mastectomy
surgery, a common treatment for early stage breast cancer [2,3].
This generalized method is based on a search heuristic known as
a genetic algorithm that mimics the process of natural evolution
and identifies reduced wavelength sets that maintain tissue optical
contrast when compared to the broadband data. It requires
a technique for measuring or simulating spectral data with known
optical contrast and a metric for data extraction quality. Diffuse
reflectance spectroscopy in the visible range can be used to nondestructively measure tissue optical properties. The propagation of
multiply scattered photons is sensitive to the absorption by
biological molecules and can ultimately provide contrast between
adipose tissue content (b-carotene absorption), vascularity (hemoglobin absorption) and scattering (fibroglandular content). During
partial mastectomy, the surgeon strives to excise the entire tumor
with a surrounding rim (or ‘‘margin’’) of normal tissue while
preserving as much normal tissue as possible in the breast.
Ultimately, the complete removal of the breast tumor is vital to
reducing the chance of tumor recurrence [4]. A previously
developed spectral imaging system for breast tumors consists of
PLOS ONE | www.plosone.org
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Figure 1. General flow chart of wavelength selection method. General flow chart illustrating the process for selecting and testing optimal
wavelength sets and spectral bandpass in clinical data obtained from breast tumor specimens and in tissue phantoms.
doi:10.1371/journal.pone.0061767.g001

optimizing wavelength selection for a cost-effective design of
spectral devices for tissue margin assessment.

Optimized selection of wavelengths and bandpass filters was
important to minimize complexity and acquisition time, while
maintaining comparable sensitivity to the relevant sources of
optical contrast in the breast. Several groups have reported on the
optimization of wavelength combinations for specific clinical
applications. Using a matrix decomposition of basis spectra and
simulation of tissue data, Mazhar et al. optimized wavelength
pairs to measure hemodynamic changes in the near-infrared range
for breast imaging applications with diffuse optical tomography
[11]. By solving a linear equation based on a modified BeerLambert Law, Umeyama and Yamada accounted for cross-talk of
measured NIR chromophores in wavelength combinations for
studying the brain [12]. Ferreira et al. presented a device
fabrication driven strategy for the spectroscopic imaging of
esophageal tissue, featuring 16 discrete wavelengths in the 350–
750 nm range [13]. The selection of wavelengths was constrained
by the filter fabrication process, i.e. materials, number of layers,
FWHM, etc. Phelps et al. developed a ratiometric method that
involves the selection of wavelength pairs that are independent of
tissue scattering to rapidly estimate total hemoglobin concentration in the UV-visible range [14]. These previous studies show the
importance of optimizing wavelength selection for various clinical
applications. Although diffuse reflectance and elastic scattering
spectroscopy [15] have increasingly been applied to breast tumor
margin assessment, few have optimized system production for
clinical translation. In this manuscript, a strategy is presented for

PLOS ONE | www.plosone.org

Figure 2. Dominant absorbers of breast tissue in the UV-visible
spectrum. Molar extinction coefficient of oxy- and deoxy- hemoglobin
and b-carotene in the 400–600 nm range.
doi:10.1371/journal.pone.0061767.g002
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pathology classified 6–10 randomly selected measurement locations (or ‘‘sites’’ on the margins). A total of 320 normal adipose
sites, 24 normal fibroglandular sites, and 38 malignant sites were
used for testing the optimized wavelength sets.
Total hemoglobin [THb], b-carotene [bc], and reduced
scattering coefficients ,ms’. for each of the 4953 diffuse
reflectance spectra were extracted using a previously developed
inverse Monte Carlo model of reflectance [5,6]. Reflectance
spectra of samples at the 10th, 25th, 50th, 75th, and 90th percentile
of the empirical cumulative distribution functions (cdf) of [THb],
[bc], and average ,ms’. were chosen resulting in a total of 15
reflectance spectra in the training set. This method ensured that
the data are sampled evenly over the distributions rather than the
parameter value ranges, which could result in oversampling of
samples at the periphery of the distributions.
Table 1 lists the extracted breast tissue properties for each of the
15 selected reflectance spectra for the wavelength optimization
training set. Samples 1–5, 6–10, and 11–15 represent the 10th
through 90th percentiles of [THb], [bc], and average ,ms’.,
respectively. The objective in selecting reflectance spectra based
on the cdfs extracted from an extensively large data set of
previously measured ex vivo breast tumor margins was to cover
a wide range of [THb] (10.7–97.9 mM), [bc] (7.0–37.6 mM), and
average ,ms’. over 450–600 nm (3.7–11.9 cm21). Thus, from
the 15 reflectance spectra, each with 3 extracted parameters to
compare, there are 45 individual parameters to compare between
the reduced wavelength spectrum extractions and the full
spectrum extractions.

Methods
Figure 1 provides a broad overview of the steps taken to
determine and test the best wavelength sets and spectral bandpass.
First, existing ex vivo breast tissue reflectance data was used as
a training set for the optimization algorithm. A fast, scalable
Monte Carlo reflectance model [5] was used to extract the tissue
optical properties from the training set using various constraints,
such as the total number of wavelengths, the range of wavelengths,
and the increment of each wavelength from which to select.
Combined with a genetic algorithm for global optimization, the
best wavelength sets are identified by minimizing the sum of tissue
property extraction errors from the reflectance spectra. The
selected wavelengths are then validated with an independent
pathology-confirmed ex vivo breast tissue data set. A tissuemimicking phantom experiment was also performed as part of
the wavelength selection validation. The text in these subsequent
sections describes the methods in greater detail.

1. Wavelength Optimization
1.1 Diffuse reflectance spectra from ex vivo breast tissue
specimens. The dominant absorbers in the visible spectrum in

breast tissue are oxy- and deoxy-hemoglobin and b-carotene. The
absorption spectra of these breast tissue components are shown in
Figure 2. Previous studies have shown that b-carotene and tissue
scattering are significant parameters that can be used to
differentiate between malignant and benign breast tissues
[2,16,17]. To select the minimum set of wavelengths in the visible
spectral range that are sensitive to these key tissue constituents, an
existing data set of 4953 diffuse reflectance spectra measured from
an ex vivo clinical study at Duke University Medical Center
approved by the Duke University Institutional Review Board
(protocol #00017428) involving partial mastectomy procedures on
100 patients was used as a training set for the wavelength
optimization [7,17]. The diagnosis for the 101 margins were as
follows: 44 negative (.2 mm normal tissue), 35 close (,2 mm
normal tissue), and 22 positive. In addition, routine histopathology
was performed on a subset of these measurements, and the study

1.2 Combined monte carlo reflectance model and genetic
algorithm to select center wavelengths. The 15 selected

reflectance spectra described from the previous section were used
in a wavelength optimization technique that combines our
previously developed inverse Monte Carlo model of reflectance
[5] with a genetic algorithm (GA) (Global Optimization Toolbox
in MATLAB, The MathWorks, Natick, MA). Briefly, the GA uses
the principles of natural selection and evolution to produce
different solutions for a given problem. For our application, the
GA is an appropriate optimization method because it can solve
every optimization problem that can be described with chromosome encoding, which is similar to various wavelength combinations. It can also provide multiple solutions for a given problem,
which is necessary from a practical system design perspective if not
all wavelengths in the solution are available commercially. The
algorithm has two major components: (1) the population of
individuals (or possible solutions) with its own unique string of
‘‘chromosomes’’ and (2) a fitness function that evaluates the
possible solutions. Typically, a population of solutions is randomly
generated for a given range of possible solutions. The fitness
function is used to evaluate each individual from that population.
All of the individuals from the populations are then ranked
according to their fitness values. From this existing population,
a user-identified proportion is selected to breed a new generation
of solutions, and those solutions with fitter values are more likely to
be selected. The parent solutions reproduce new offspring
solutions by genetic operators such as crossovers or mutations,
which essentially results in changes of chromosomes in the
offspring and maintains genetic diversity in the subsequent
populations. The GA ends when a solution that satisfies the
criteria is found, a designated computational time is reached, or
a specified generation number is reached. Figure 3 is a general
diagram of the steps taken for wavelength optimization, combining
an inverse Monte Carlo reflectance model with the GA.
The algorithm begins with the initial constraints of the
wavelengths to be used. To extract the 4 parameters of oxy-

Table 1. Extracted ex vivo breast tissue properties used for
training set.

Sample

[THb] (mM)

[b-carotene] (mM)

,ms’.450–600 (cm21)

1

10.7

7.5

4.1

2

18.1

21.7

5.3

3

32.7

18.6

11.5

4

59.3

21.0

8.0

5

97.9

16.6

4.4

6

55.7

7.0

3.9

7

49.6

11.3

9.2

8

32.8

17.5

6.3

9

73.1

26.0

8.8

10

95.9

37.6

8.4

11

24.2

13.6

3.7

12

22.3

29.3

4.8

13

40.3

31.3

6.5

14

91.1

15.8

8.9

15

11.5

30.8

11.9

doi:10.1371/journal.pone.0061767.t001
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Figure 3. Diagram of combined Monte Carlo reflectance model and genetic algorithm. Diagram detailing the steps of selecting
wavelengths for quantitative tissue spectroscopy using the genetic algorithm and inverse Monte Carlo model.
doi:10.1371/journal.pone.0061767.g003

hemoglobin, deoxy-hemoglobin, b-carotene, and reduced scattering coefficients, at least 5 center wavelengths are needed. The
initial population of wavelength sets is created by a random
permutation of 50 different wavelength combinations, for 5, 8, and
12 wavelengths in 1, 5, and 10 nm increments from 450–600 nm
(151, 31, and 16 possible center wavelengths, respectively). The
selection of wavelengths in 1 nm increments represents an ideal
situation in system design in which the types of sources available
are not limited. The selection of wavelengths in 5 and 10 nm
increments represents a more realistic situation, in which the final
optimized set of wavelengths will likely be commercially available
in the form of bandpass filters. These different wavelength

combinations serve as the initial solutions of the iterative GA.
The inverse MC model serves as the GA’s fitness function, which is
used to evaluate the suitability of each set of wavelengths as
a possible solution for extracting ,ma., thus [THb] and [bc], and
,ms’. from the training set.
In the 1st generation of a given GA process with its constraint of
total wavelengths and the selection increment, the output of the
fitness function is 50 sets of extracted breast tissue properties,
[THb], [bc], and average ,ms’., for 15 samples using each of the
50 reduced wavelength solution sets. The fitness value was the
RMS error between the extracted tissue parameters ([THb], [bc],
and average ,ms’.) using the reduced wavelength set and using
the full 450–600 nm spectrum. Fifty individual wavelength sets
were ranked by increasing fitness values (sum of extracted errors)
for the 15-sample training set. From these 50, the top 15
wavelength sets with the lowest sum of extracted errors are
duplicated to create a new generation of solutions. These same 15
wavelength sets were also used to generate 35 new wavelength sets
by means of single-point crossovers or wavelength mutations. In
a crossover operation, a random wavelength serves as the point
where two wavelength sets break and join. In a mutation
operation, a new wavelength is randomly generated from
a Gaussian distribution and replaces a wavelength of the parent
wavelength set, creating a new wavelength set. The selection of the
parent wavelength sets from the previous generation to crossover
or to mutate and pass on to the next generation is based on the
simulation of a roulette wheel, in which the area of the wheel
corresponding to a parent is inversely proportional to the parent’s
fitness value, or sum of extracted errors. In other words, the lower
the wavelength set’s extracted errors, the higher the probability of
that wavelength set is selected, crossed over or mutated, and

Table 2. Average ma (450–600 nm) of liquid phantoms
containing hemoglobin, crocin, and polystyrene
microspheres.
Absorber Level 1 Avg ma (cm21)

Absorber Level 2 Avg ma (cm21)

Total

Hb

Cr

Total

Hb

Cr

0.51

0.51

0.00

0.91

0.91

0.00

0.99

0.51

0.48

1.72

0.90

0.82

1.23

0.51

0.72

2.12

0.89

1.23

1.47

0.51

0.96

2.53

0.89

1.64

1.70

0.50

1.20

2.93

0.88

2.05

a

Each absorber level was tested for 2 scattering levels (avg ms’ = 9 cm21 and avg
ms’ = 12 cm21) for a total of 20 phantoms.
doi:10.1371/journal.pone.0061767.t002
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Table 3. Top solutions for each optimization with varied
increments and total number of wavelengths.

l range

# of lsOptimized Wavelengths

450:1:600 12

8

5

450:5:600 12

8

5

450:10:600 12

8

5

Error

451 460 474 483 487 502 511 560 579 584
585 596

11.7%

451 460 474 483 502 509 511 560 573 584
585 596

11.8%

466 479 491 500 516 527 532 560 566 574
590 597

12.0%

474 481 498 509 555 573 593 596

12.2%

489 492 503 522 537 558 583 592

12.3%

485 492 503 510 537 544 560 593

12.5%

485 496 512 547 589

18.1%

478 499 513 582 596

19.5%

482 496 527 576 597

19.7%

460 470 485 490 505 525 530 535 550 570
575 600

11.9%

460 470 475 480 485 500 515 525 530 555
585 595

12.2%

455 465 470 490 505 510 515 530 550 560
590 595

12.4%

470 485 495 500 510 550 580 600

12.4%

460 485 500 510 555 560 580 600

12.7%

450 480 500 505 545 555 585 600

13.2%

485 495 510 540 590

18.5%

490 520 525 570 595

18.7%

485 495 510 545 595

19.9%

450 470 480 490 500 510 520 530 540 560
580 600

12.0%

460 470 480 490 510 530 540 550 560 570
580 600

12.1%

450 460 490 500 510 530 540 550 560 570
580 600

12.3%

460 490 510 520 540 550 580 600

12.4%

470 480 490 500 510 560 580 600

12.6%

480 500 510 530 550 560 570 600

13.3%

480 490 520 540 590

19.0%

480 490 520 550 600

19.9%

450 490 520 530 590

20.3%

Figure 4. Average of extracted errors for tissue parameters
with increasing number of wavelengths. Average extracted %
error of [THb], [bc], and ,ms’. for 5, 6, 7, 8, and 12 total wavelengths
selected from 450–600 nm in 1 and 10 nm increments.
doi:10.1371/journal.pone.0061767.g004

solution given their respective constraints prior to reaching 50
generations. A single optimization requires approximately 21–28
hours, depending on the initial constraints tested, such as the
number of wavelengths implemented and the selection increment.
The highest ranked 3 solutions from the final generation produced
by each GA process were further evaluated using previously
described clinical data, independent from the 15 spectra used in
the selection process.
1.3 Selection of optimal bandpass. In addition to selecting
the most appropriate total number and the center wavelengths of
the source, it is also important to understand the effect of
increasing full-width half-maximum (FWHM) on the accuracy of
the extraction of optical properties. While laser diodes can have
very small FWHM, it may not be possible to obtain sources at
every wavelength in the optimized solutions. On the other hand,
bandpass filters are commercially available at every 10 nm center
wavelength in the UV-NIR spectrum, but may come at a cost of
10 nm FWHM around the center wavelength. Light emitting
diodes (LEDs) often have even larger FWHM, commonly ranging
from 20–50 nm.
Forward Monte Carlo simulations were conducted to study the
effect of increasing bandpass. Using the wavelength-dependent
optical properties of the 15 clinically measured spectra chosen for
the training set described in Section 2.1, diffuse reflectance spectra
were generated. The wavelength-dependent absorption coefficients, ma, were determined using the molar extinction coefficients
for oxy- and deoxy-hemoglobin, as well as b-carotene. The
reduced scattering coefficients, ms’, at each wavelength were
calculated using Prahl’s Mie scattering program [18]. The
simulations were scaled for the probe geometry used in the
clinical measurements [5]. Each of the 15 simulated spectra were
convolved with Gaussian distributions of 1, 5, 10, 20, 30, 40, and
50 nm, resulting in a total of 105 spectra of varying FWHM.
The inverse Monte Carlo model was used to extract [THb],
[bc], and average ,ms’. values from the 15 reflectance spectra
with various FWHMs. The extractions were repeated for the top 3
solutions from the wavelength optimizations for 5, 8, and 12 total
center wavelengths. The extracted parameters from the reduced
wavelengths set with added FWHM were compared to those of the
full, simulated spectra without added FWHM. Because these
simulations did not include system and measurement artifacts that

The error from the optimization is the minimized average errors of the
extracted parameters from the 15 representative reflectance spectra chosen
from the breast tissue data set.
doi:10.1371/journal.pone.0061767.t003

passed down to be part of the next 50 solutions to be evaluated.
Because higher crossover fractions result in less diversity in the
subsequent generations and we also found no significant differences in computational time or solutions for various crossover
fractions ranging from 0–40%, in this particular study, the
crossover fraction is set at 20%, which means 7 of the 35 solutions
are the result of a crossover while the remaining 28 are the result
of mutations. In the cases of any resulting offspring from
a crossover operation having duplicate wavelengths, one of the
duplicate wavelengths is discarded, and a new wavelength is
randomly generated and inserted in the wavelength set. This
process iterates until the minimum fitness value of the generation is
unchanged for 10 generations or after 50 generations. All of the
GA processes tested in this study converged to an optimum
PLOS ONE | www.plosone.org
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Figure 5. Effect of increasing spectral bandpass. (a) Simulation of the effect increasing spectral bandpass on a diffuse reflectance spectrum
representing 10 mM [THb], 5.5 mM [bc], and 3.11 avg ,ms’.. (b) Average extracted errors of [THb], [bc], avg ,ms’. with increasing spectral bandpass.
doi:10.1371/journal.pone.0061767.g005

(ms’ = 12 cm21) breast tissue. The optical properties of the
phantoms are shown in Table 2.
The phantom optical measurements were obtained with
a previously reported system with slight modifications [1,9] The
system consists of a 450W Xenon Arc lamp and a scanning
monochromator (Gemini 180, JY Horiba) coupled to a 600 mm
optical fiber as the source. The spectral bandpass of the
illumination was fixed at 7 nm. A custom annular silicon
photodiode with 2.5 mm outer diameter and 0.75 mm inner
diameter was used for detection [21]. The optical fiber was fitted
through and epoxied in the detector aperture to illuminate the
phantoms, and the detector was connected to a photodiode
amplifier (PDA-850, Terahertz Technologies, Inc.) for reflectance
measurements. Diffuse reflectance measurements were taken at
the discrete wavelength solutions as well as at the evenly spaced
wavelengths from 400–600 nm in order to compare the optimized
solution to one which samples wavelengths at regularly spaced
intervals over the visible spectral range as previously described [8].
The inverse Monte Carlo model was used to extract optical
properties from each phantom and root mean square (RMS)
errors were compared for both sets of wavelengths.

may exist in measured clinical data, a 10% error was set as the
threshold for determining an acceptable FWHM in the analysis.

2. Wavelength Selection Validation
2.1 Independent pathology-confirmed tissue data. The
results from the wavelength optimization were tested against an
existing breast tissue data set, independent of the 15 spectra used
for the training set described previously. The inverse Monte Carlo
model was used to extract [THb], [bc], and ,ms’. from each of
the 382 pathological confirmed sites (320 adipose, 24 fibroglandular, 38 malignant) obtained from breast tumor margins. The
tissue extractions were performed for the full spectrum of 450–
600 nm in 2.5 nm increments for a total of 61 wavelengths, and
for the top 3 optimized solutions for each of the test cases: 5, 8, and
12 total wavelengths in 1, 5, and 10 nm increments. To show the
differences between optimization and non-optimization, tissue
extractions were also made using the semi-evenly spaced
wavelengths empirically chosen from 400–600 nm used in a previously reported system [19]. Using the full spectrum [THb], [bc],
and ,ms’. extractions as the gold standard, errors in the extracted
parameters resulting from the reduced wavelength sets were
calculated. The Bland-Altman method was used to assess the
agreement between the extractions using the full spectrum and the
extractions using the optimized and non-optimized spectra.
2.2 Multi-absorber liquid phantom study. A set of 20
phantoms was used to further assess the results from the
wavelength optimization. The liquid tissue-simulating phantoms
were prepared by mixing polystyrene microspheres (07310,
Polysciences, Inc) as the scatterer with water soluble hemoglobin
(H0267, Sigma Co.) and crocin (17304, Fluka) as the absorbers.
Hemoglobin and crocin were used as the absorbers since they have
been used to simulate blood and b-carotene in breast tissue [20].
Based on the optical properties of b-carotene found in previous
studies, the appropriate crocin level was added by matching the
mean ma of these two absorbers with similar spectral features [2].
The 2 scattering levels represent the means over 450–600 nm of
and
normal
representative
malignant
(ms’ = 9 cm21)
PLOS ONE | www.plosone.org

Results
1. Eight Wavelengths can be Used to Accurately Extract
[THb], [bc], and ,ms’.
Table 3 enumerates the top 3 solutions for each of the
constraints in the optimization, including wavelength range,
increment, and total number of wavelengths. For the optimized
solutions chosen from 450–600 nm in 1 nm increments, the
average errors of extracted THb, bc, and ms’ from the 15 tissue
reflectance spectra increases from 11.7% to 12.2% to 18.1% as the
total number of wavelengths used decreases from 12 to 8 to 5.
When selecting in 5 nm and 10 nm increments, the errors increase
from 11.9%–18.5% and 12.0%–19.0% as the wavelengths decrease from 12 to 5, respectively. This trend is not unexpected
because as the total number of wavelengths as well as available
6
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Table 4. Summary of average extracted errors of parameters for various tissue types for the top 3 optimized solutions.

Constraints

[THb]

[bc]

,ms’.

# of l, increment

Tissue

Set1

Set2

Set3

Set1

Set2

Set3

Set1

Set2

Set3

12l: 450:1:600

A

3.1

2.4

4.5

23.9

25.5

210.8

9.3

3.0

7.8

FG

3.9

3.4

5.6

213.9

215.9

215.7

4.2

3.9

11.8

M

3.0

3.9

24.8

2.1

22.5

211.9

8.9

2.1

5.3

12l: 450:5:600

12l: 450:10:600

8l: 450:1:600

8l: 450:5:600

8l: 450:10:600

5l: 450:1:600

5l: 450:5:600

5l: 450:10:600

ES8l: 400–600

A

3.8

2.0

5.6

27.9

24.6

22.4

6.4

11.7

2.7

FG

2.0

8.8

12.2

27.6

210.1

211.4

11.2

4.9

10.0

M

22.8

6.0

5.9

22.7

25.2

27.0

2.7

6.2

7.7

A

4.0

22.2

6.0

22.8

28.7

211.5

1.4

3.8

9.3
15.7

FG

7.7

9.7

10.4

29.6

217.3

214.9

3.2

10.8

M

6.6

26.5

4.7

24.4

28.5

29.5

2.0

24.0

7.7

A

8.5

5.5

11.0

23.0

21.4

25.7

6.6

8.8

7.9
11.1

FG

22.6

10.4

8.7

27.0

218.9

212.0

6.6

13.5

M

4.1

28.2

11.9

4.4

23.0

3.2

8.5

5.0

7.7

A

7.1

7.0

8.2

22.9

24.7

26.1

8.6

9.0

8.9
15.5

FG

5.9

8.5

11.9

26.8

218.2

210.0

13.3

14.6

M

5.3

7.7

8.2

2.9

27.7

2.1

7.1

8.7

8.7

A

11.7

6.7

13.9

212.2

24.8

213.2

4.8

2.2

9.1
14.8

FG

13.9

7.2

7.1

215.4

28.8

210.0

9.0

4.5

M

211.8

7.5

12.9

219.2

22.9

29.4

1.1

2.8

8.1

A

22.2

23.3

21.0

220.8

210.2

10.1

17.2

16.6

15.6

FG

23.3

28.4

27.0

10.9

218.1

12.5

22.8

23.5

23.2

M

21.0

25.3

25.9

13.6

11.8

13.8

16.8

18.2

18.3

A

22.3

26.4

23.4

23.7

223.2

24.0

18.4

18.7

18.2

FG

27.1

29.3

20.9

28.1

220.6

28.0

25.1

23.5

24.4

M

23.4

26.6

22.8

18.8

221.2

18.7

19.6

25.4

18.3

A

16.0

21.4

24.4

26.9

28.8

25.1

24.7

24.9

21.9

FG

13.3

21.8

17.9

22.5

23.8

28.1

29.6

29.8

29.0

M

19.7

15.6

220.3

25.1

23.4

221.5

20.9

22.0

221.1

A

22.5

14.0

FG

23.6

64.4

218.3

M

17.3

15.7

226.3

215.5

Positive values indicate an over-estimation of the extracted parameters while negative values indicate an under-estimation of the parameters. [THb]: total hemoglobin;
[bc]: b-carotene; ,ms’.: reduced scattering coefficient; A: adipose tissue; FG: fibroglandular; M: malignant tissue; ES8l: semi-evenly spaced 8 wavelengths (400, 420, 440,
470, 500, 530, 570, 600 nm).
doi:10.1371/journal.pone.0061767.t004

center wavelength choices decrease, the possibility of capturing the
spectral features of the absorbers and scatterers in tissue also
decreases, thus increasing the extracted errors.
Figure 4 puts into perspective the optimal number of
illumination wavelengths required for the design of a breast
spectral imaging system. At 5 wavelengths, the average extracted
percent error of [THb], [bc], and ,ms’. from the 15
representative breast tissue reflectance spectra was close to 20%.
The increase to 6, 7, and 8 wavelengths improved the extraction
errors to 14%, 13%, and 12%, respectively. There are diminishing
returns in improving extraction errors by adding more wavelengths past 8. The graph shows that for our particular application
for breast tumor margin assessment, the appropriate number of
wavelengths to use is 8.

PLOS ONE | www.plosone.org

2. Spectral Bandpass Affects Extraction Accuracy
Because the system used to obtain the existing breast tumor
margin data had a spectral bandpass of 3.9 nm, it is challenging to
evaluate the effect of changes in bandpass and to optimize both the
wavelengths and bandpass of a system. The forward MC model
was used to simulate the same 15 reflectance spectra used in the
wavelength optimization. The original spectra were degraded to
simulate increases in spectral bandpass of 5, 10, 20, 30, 40, and
50 nm. Representative reflectance spectra (10 mM [THb], 5.5 mM
[bc], and 3.11 avg ,ms’.) with these changes in spectral bandpass
are shown in Figure 5(a). The extracted errors from each case are
shown in Figure 5(b). The results in Figure 5(b) show that to
extract the breast tissue properties with good accuracy, the
wavelengths must have ,10 nm FWHM, and 8 or more
wavelengths have to be implemented in the system design.
Parameter extraction accuracies are affected by not only the
number of wavelengths and the center wavelengths used, but also
7
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the shape of each LED spectrum can be added to the MC forward
model, which computes a lookup table of ‘‘LED-modified’’
reflectance spectra for a wide range of optical properties. The
inverse MC model can then be used to extract optical properties
from samples measured with the system with the specified LEDs as
sources.

Table 5. Summary of average extracted errors of the ratio of
[THb]/,ms’. and [bc]/,ms’. for various tissue types for the
top 3 optimized solutions.

Constraints

[THb]/,ms’.

[bc]/,ms’.

# of l, increment

Tissue

Set1 Set2 Set3 Set1 Set2 Set3

12l: 450:1:600

A

22.9 24.5 28.4 215.426.6 210.8

12l: 450:5:600

12l: 450:10:600

8l: 450:1:600

8l: 450:5:600

8l: 450:10:600

5l: 450:1:600

5l: 450:5:600

5l: 450:10:600

ES8l: 400–600

FG

27.0 21.5 213.3213.1210.9212.7

M

23.7 24.2 28.3 27.9 22.1 28.7

A

26.1 0.3

FG

29.8 27.7 24.9 212.8215.9213.1

0.7

3. Optical Contrast in Breast Tissue is Retained with
Optimized Wavelength Choices
The top 3 optimized solutions with 5, 8, and 12 total
wavelengths selected from 450–600 nm in 1, 5, and 10 nm
increments were tested in an independent partial mastectomy
tissue data set. Although the initial 15 reflectance spectra selected
in the training set spanned the 10th to 90th percentiles of [THb],
[bc], and ,ms’., in this large data set the histological diagnoses of
the tissues corresponding to these spectra were not known.
Therefore, a subset of measurements for which diagnosis was
histopathologically confirmed was used to independently test the
optimized wavelengths, and were split into 3 tissue types: adipose,
fibroglandular, and malignant.
Table 4 and Table 5 provide a summary of all errors extracted
for the top 3 optimized solutions for each tissue type and for 5, 8,
and 12 wavelengths in 1, 5, and 10 nm increments. A positive
percent error value indicates an over-extraction by the reducedwavelength solutions; a negative value indicates an underestimation of the extracted parameters. When the number of
wavelengths is increased from 8 to 12, the sum of absolute values
of the extracted errors for the 3 parameters for any given set of
solutions did not improve drastically, which was expected based on
the findings shown in Figure 4. When the total number of
wavelengths used is decreased from 8 to 5, however, the extracted
errors are increased. For solutions selected in 1 nm increments, the
extracted [THb] from normal adipose, normal fibroglandular, and
malignant tissues using 8 wavelengths differed by 8.5%, 22.6%,
and 4.1% from the full 61-wavelength set, respectively. When the
wavelengths were reduced to 5, the errors increased to 22.2%,
23.3%, and 21.0% for the 3 tissue types. Similarly, with 8
wavelengths, the extracted [bc] errors for the adipose, fibroglandular, and malignant tissues were 23.0%, 27.0%, and 4.4%. With
just 5 wavelengths, the errors increased to 220.8%, 10.9%, and
13.6%. The extracted reduced scattering coefficient errors were
also more than doubled (6.6–8.5% to 16.8–22.8%) when total
wavelengths decreased from 8 to 5. Because the motivation for this
work is to provide a method of optimizing wavelength choices for
a compact, cost-effective, and fast spectral imaging device that also
has a simplistic design, the solutions with 12 total wavelengths
were eliminated and only 8 total wavelengths are used for
subsequent system design to be described in a future work.
Although the top optimized solution for each wavelength
selection constraint had the lowest average errors of [THb], [bc],
and ,ms’. extracted from the 15 representative reflectance
spectra in the training set, the best choice of wavelengths from the
independent breast data set validation is not necessarily the same
as the best solution from the training set. This is possibly due to the
relatively small size of the training set. However, the differences in
errors between the top 3 optimized solutions are also small, which
indicates that the solutions have been minimized. The best
wavelength set for extracting optical parameters with the lowest
errors in the histopathology confirmed data set is solution #1: 474,
481, 498, 509, 555, 573, 593, 596 nm for the wavelengths selected
in 1 nm increments. The best wavelength set selected from 5 nm
increments is also solution #1: 470, 480, 495, 500, 510, 550, 580,
600 nm. However, the best wavelength set selected from 10 nm
increments is solution #2: 470, 480, 490, 500, 510, 560, 580,

25.6 25.7 29.8

M

26.4 20.5 22.2 26.3 211.728.9

A

23.0 26.5 24.1 26.1 28.8 213.7

FG

26.0 28.4 26.9 212.2212.8216.8

M

23.4 23.9 24.0 25.6 29.8 29.2

A

24.8 26.0 27.3 211.3212.7215.1

FG

21.4 21.5 21.2 210.1218.6216.4

M

22.5 26.1 26.9 28.5 29.6 25.1

A

21.8 22.6 25.9 23.4 216.9217.3

FG

25.3 27.4 24.7 214.1212.029.9

M

22.5 21.7 21.3 25.2 29.0 27.6

A

28.6 4.2

26.0 8.3

FG

25.8 2.2

29.4 19.0 14.4 19.9
26.3 10.0 4.3

7.6

15.0

M

28.5 4.4

A

17.4 18.4 16.7 221.6232.3218.4

9.6

FG

13.1 16.3 12.7 228.7230.4224.0

M

15.3 21.0 19.8 223.5219.8214.7

A

16.1 220.417.3 228.0221.9227.6

FG

14.6 218.314.4 223.8232.8222.4

M

15.9 223.716.1 223.3222.820.2

A

217.6216.7217.723.1 28.8 226.9

FG

217.4217.2216.7223.524.3 220.8

M

222.025.8 218.0221.224.8 220.9

A

44.0

35.3

FG

26.6

102.1

M

70.1

75.5

Positive values indicate an over-estimation of the extracted parameters while
negative values indicate an under-estimation of the parameters. [THb]: total
hemoglobin; [bc]: b-carotene; ,ms’.: reduced scattering coefficient; A: adipose
tissue; FG: fibroglandular; M: malignant tissue; ES8l: semi-evenly spaced 8
wavelengths (400, 420, 440, 470, 500, 530, 570, 600 nm).
doi:10.1371/journal.pone.0061767.t005

by the spectral bandpass of the wavelengths. It has been shown
through existing clinical data that using 5 wavelengths is likely
inadequate for accurate extractions of breast properties. The
simulations on the effect of widening spectral bandpass also show
that the errors with 5 wavelengths are nearly double those of 8.
Similar to previously measured data, the increase from 8 to 12
wavelengths did not seem to have a significant impact on
improving the extraction accuracy. Because commercially available LEDs have a much larger bandpass than the 10 nm identified
here, more work is required to realize a compact, energy-saving
spectral imaging system. Additional filters can be used to narrow
the bandpass at each wavelength, or each of the LED spectra can
be accounted for with the Monte Carlo reflectance model. Briefly,
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Table 6. Comparison of the percent difference between median adipose and malignant tissue and fibroglandular and malignant
tissue to the percent change of extractions using the optimized wavelengths and evenly spaced wavelengths to the full 450–
600 nm spectrum.

Medians

% Difference

Extraction % change from full 450–600 nm spectrum

Full spectrum (450–600)

Optimized 8 ls

Semi-evenly spaced 8 ls

A vs. M

FG vs. M

A

FG

M

A

FG

M

[THb]

240.66

225.16

8.90

10.48

2.63

215.09

5.64

21.28

[bc]

9.90

29.54

24.54

28.74

20.76

22.74

235.39

26.79

,ms’.

236.89

22.83

1.15

11.72

2.21

18.05

26.88

27.89

[THb]/,ms’.

22.75

262.18

1.84

21.40

0.43

240.43

229.04

240.45

[bc]/,ms’.

13.07

287.48

25.75

223.18

21.99

225.36

285.15

212.12

[THb]: total hemoglobin; [bc]: b-carotene; ,ms’.: reduced scattering coefficient; A: adipose tissue; FG: fibroglandular; M: malignant tissue; Positive percent difference
indicates that the benign tissues (A and FG) had greater extracted values; negative percent difference means the malignant sites were greater. A positive extraction
percent change indicates an over-estimation of the extracted parameters while a negative percent change indicates an under-estimation of the parameters.
doi:10.1371/journal.pone.0061767.t006

differentiate benign from malignant samples may be washed out
if the un-optimized wavelengths are used. By examining the
percent differences between optical parameters of benign and
malignant samples and the mean extracted errors from Table 4
and Table 5, it was also further established that none of the top
wavelength sets with only 5 wavelengths can be used for our
clinical application because most of the extracted errors are
greater than percent differences of the optical parameters for the
various breast tissue types tested.
Figure 6 shows the Bland-Altman plots comparing the
extractions between the optimum 8-wavelength set and the evenly
spaced 8-wavelength set with the full 450–600 nm 61-wavelength
set. The various tissue types are shown in columns, and the
extracted parameters are shown in rows. The mean difference (or
bias between the optimized reduced and full wavelength extractions) and 95% limits of agreement for [THb] are 1.5610.6,
3.2611.6, and 2.3611.3 mM for adipose, fibroglandular, and
malignant tissue types, respectively. By comparison, the evenly
spaced 8-wavelength extractions do not agree as well for extracting
[THb], with the mean difference and 95% limits of agreement at
210.0635.2, 24.4651.8, and 22.2646.3 mM for the three tissue
types. Similar trends are observed for the extraction of [bc] and
,ms’.. The mean differences between the opimized 8 wavelengths and the 61-wavelength spectrum for the extraction of [bc]
are close to 0 with a much smaller range of limits of agreement for
various tissue types: 20.762.7, 20.763.9, and 20.461.7 mM. By
comparison, the un-optimized evenly spaced wavelengths have
a larger difference and wider range: 21.969.3, 27.1614.9, and
1.8637.1 mM. For scattering, the optimal wavelengths also
performed better: 0.261.1, 0.362.0, and 0.261.6 cm21 compared to 1.162.5, 2.067.5, and 3.167.0 cm21. Because previous
studies have shown that [bc] and ,ms’. are significant parameters
that provide optical contrast for breast tumor margin assessment,
these results further show the importance of optimizing wavelength choices.
Figure 7 contains representative breast tumor margin images of
extracted [bc]/,ms’. for a negative (normal) and two positive
breast resection margins: ductal carcinoma in situ (DCIS) and
invasive ductal carcinoma (IDC). The margin images shown in (a),
(e), and (i) were obtained using the full 450–600 nm spectrum. The
images shown in (b), (f), and (j) were extracted using the optimized
solution for 8 wavelengths: 470, 480, 490, 500, 510, 560, 580, and
600 nm. The images shown in (c), (g), and (k) were extracted using

600 nm. The wavelengths selected from 1 nm increments from
450–600 do have striking similarities with those selected from both
the 5 nm and 10 nm increments. From a practical system design
standpoint, this is a good finding because of the abundant
availability of sources in 10 nm increments, such as those of LEDs.
On the other hand, the wavelengths selected from 1 nm
increments (and some wavelengths in 5 nm increments) in the
450–600 nm range are not all commercially available to date.
Since wavelength choices in both the 5 nm and 10 nm increments
did not yield significantly different extracted errors, the 8
wavelengths selected in 10 nm increments (solution #2) were
chosen for subsequent analyses in this study: 470, 480, 490, 500,
510, 560, 580, and 600 nm, which are all commercially available
filters with 10 nm bandpasses. A practical low-cost implementation for these center wavelengths would be to use a white LED
together with the respective bandpass filters.
The optimization helped identify wavelength sets that can be
used to extract tissue parameters with errors ,20%; however, the
acceptable extraction errors for [THb], [bc], and ,ms’. has to be
determined based on the contrast of these optical endpoints in
various tissue types. In Table 6, the percent difference of
quantifiable optical contrast was calculated between the histologically-confirmed median adipose and malignant tissue samples, as
well as the median fibroglandular and the malignant samples. A
positive percent difference indicates that the benign (adipose or
fibroglandular) tissue samples had greater extracted values than
those of the malignant sample. The malignant sample showed
decreased [THb] and ,ms’. compared to the adipose samples
and decreased [THb] and [bc] compared to the fibroglandular
sample. Also in the table are the extraction percent changes from
the full 450–600 nm spectrum compared to the 8 optimized
wavelengths and the 8 evenly spaced wavelengths. A positive
percent change indicates an over-estimation of the extracted
values by the 8-wavelength reduced spectra compared to the full
450–600 nm spectrum. A negative percent change means that the
extracted values are decreased using 8 wavelengths.
The percent change using the optimized wavelengths is smaller
than the percent difference for all optical parameters so optical
contrast should be preserved with these reduced wavelengths. On
the flip side, the percent change using the evenly spaced
wavelengths without any optimization is sometimes greater than
the percent difference for the optical parameters, such as for [bc]
and [bc]/,ms’.. This means that the optical contrast to
PLOS ONE | www.plosone.org
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Figure 6. Bland-Altman plots of MC extractions using various wavelength combinations. Bland-Altman plots assessing the agreement of
MC extractions of [THb], [bc], ,ms’., [THb]/,ms’., and [bc]/,ms’. in adipose, fibroglandular, and malignant tissue types using the full spectrum
versus the optimized reduced wavelength spectrum with 8 wavelengths (470, 480, 490, 500, 510, 560, 580, 600 nm) shown in black and the regularly
spaced intervals (400, 420, 440, 470, 500, 530, 570, 600 nm) shown in red. The solid lines indicate the mean difference (bias) between the extractions;
the dashed lines indicate the 95% limits of agreement.
doi:10.1371/journal.pone.0061767.g006

the optimized 8 wavelengths, the contrast in breast margins is
preserved. Without the optimization, some contrast is lost. These
margin maps can potentially help surgeons identify suspicious ‘‘hot
spots,’’ where cancer cells may be present at the surface of the
excised specimen.
Wilcoxon Rank Sum tests were performed to compare the
Monte Carlo extracted optical properties using the full 61 and
reduced wavelengths, both the optimized and evenly spaced 8.
The boxplots of the comparisons are shown in Figure 8. The
histologically normal samples were comprised of 320 adipose and
24 fibroglandular samples (total N = 344) compared to the 38
malignant samples. The extractions of [THb], [bc], and ,ms’.
using the optimized 8 and 61 wavelengths were not significantly

the evenly spaced 8 wavelengths used in a previous system: 400,
420, 440, 470, 500, 530, 570, and 600 nm. The correlation
coefficients for the images extracted with optimized 8 wavelengths
(as compared to the images extracted using the full 61-wavelength
set) were 0.98, 0.96, and 0.95 for the normal, DCIS, and IDC
margins, respectively. The correlation coefficients for the evenly
spaced 8 wavelengths were 0.77, 0.81, and 0.53. Histograms are
shown in (d), (h), and (l) to compare the extracted [bc]/,ms’.
using 61 wavelengths versus just 8 wavelengths with and without
optimization. Wilke et al. reported using a threshold of 6 for the
[bc]/,ms’. ratio for classifying negative and positive margins [7].
If 98% of the pixels that make up the margins have a ratio ,6, the
margin is then classified as positive. The histogram shows that with
PLOS ONE | www.plosone.org
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Figure 7. Example spectral images of negative and positive margins obtained with and without optimization. Representative margin
maps of [bc]/,ms’. for normal (A–C), ductal carcinoma in situ (E–G), and invasive ductal carcinoma (I–K) using the full 450–600 nm spectrum, the
optimized 8 wavelengths, and the un-optimized evenly spaced 8 wavelengths. Corresponding correlation coefficients for the 61-wavelength spectra
and the reduced 8-wavelength spectra are shown. Distribution of the extracted bc/ms’ are shown in (D), (H), and (L) for each case, along with the
threshold values used in the predictive model to separate positive from negative margins.
doi:10.1371/journal.pone.0061767.g007

in future studies with a new compact device with the optimized
wavelengths implemented.

different for all tissue types. The findings from an observational
study on the effects of tissue heterogeneity reported by Kennedy
et al were also duplicated [17]. [THb] and ,ms’. were both
significantly increased in the malignant samples compared to the
normal samples. Using the evenly spaced 8 wavelengths that were
selected empirically for a previous system, the extracted ,ms’. is
most notably underestimated for malignant samples while the
[THb] and the ratio [bc]/,ms’. are overestimated. These are
consistent with the Bland-Altman plots shown in Figure 6. Without
wavelength optimization, the contrast between benign and
malignant samples for [THb] and ,ms’. is not retained as
wavelength numbers are reduced to the 8 evenly spaced
wavelengths. Although these results show that a reduced wavelength set can be used in place of the full wavelength spectrum to
obtain optical contrast in previously acquired breast tissue data,
which have disproportionally large number of adipose normal
tissue, the main goal of this study is not to show the predictive
power for separating normal from tumor, but rather it is to find
a reduced number of wavelengths that can be used to extract
reasonably similar tissue parameters compared to the full
spectrum. With the ability to extract similar tissue parameters
from previous clinical studies reported by Wilke et al. and
Kennedy et al., we expect to have similar success in classification

PLOS ONE | www.plosone.org

4. Wavelength Optimization Improves Extraction
Accuracy in Phantoms
Figure 9 compares the extraction accuracy in the multi-absorber
liquid phantom study using the full 450–600 nm range, the
optimized wavelengths, and the evenly spaced wavelengths that
were chosen empirically for a previously reported system [22]. The
RMS errors for the extraction of [Hb], [Cr], and ,ms’. using the
61 wavelengths in the 450–600 nm range were 4.764.4%,
3.863.8%, and 3.762.4%, respectively. However, using the 8
evenly spaced wavelengths without any optimization, the RMS
errors are 15.3612.5% for [Hb], 10.769.9% for [Cr], and
10.561.9% for ,ms’.. With the optimized 8 wavelengths, the
RMS errors of extracted [Hb], [Cr], and ,ms’. were decreased to
6.665.6%, 4.163.7%, and 4.963.0%, respectively. These errors
are not significantly different from the errors from the full 450–
600 nm spectrum. Referring back to Table 6 for an approximation of acceptable errors, these phantom results show the benefit of
wavelength optimization for extracting hemoglobin and a bcarotene substitute while maintaining optical contrast, which is of
utmost importance for our application.
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Figure 8. Comparison of Monte Carlo extractions of normal and cancerous tissue parameters. Comparison of the MC extractions of
[THb], [bc], ,ms’., [THb]/,ms’., and [bc]/,ms’. in adipose, fibroglandular, and malignant tissue types using full spectrum versus the optimized
reduced wavelength spectrum and evenly spaced spectrum with 8 wavelengths. Sample sizes are Normal (N) = 344, and Tumor (T) = 38.
doi:10.1371/journal.pone.0061767.g008

wavelengths to retain optical contrast obtained from a full 450–
600 nm set is 8 wavelengths. Designing a system with additional
wavelengths up to 12 provides minimal improvements in
extraction errors at a potentially higher cost of increasing system
footprint, data acquisition time, and system design complexity.
Additionally, a two-absorber turbid phantom study showed
improved quantitative accuracy for optimized wavelength sets.
This method may be adapted to the optimization of other
quantitative spectroscopic imaging instruments in clinical applications beyond breast tumor margin assessment.

Conclusions
A method that combines a genetic algorithm and inverse Monte
Carlo reflectance model was applied and validated in an
independent clinical dataset to systematically select wavelengths
and bandwidths in the design of a spectral imaging system for the
application of breast tumor margin assessment. The development
of this method was motivated by the system design for a compact,
cost-effective spectral imaging system, which features a white LED
with bandpass filters. We demonstrate that at least 5 wavelengths
are required to extract oxy- and deoxy-Hb, bc, and ms’ for this
acquisition geometry. We found that the minimum number of

Figure 9. Multi-absorber phantom optical properties extracted with and without optimization. Comparison of extraction accuracy for
[Hb], [Cr], and ,ms’. using the full 450–600 nm spectrum, the optimized wavelength solution, and the evenly spaced wavelengths selected
empirically for a previously reported system.
doi:10.1371/journal.pone.0061767.g009
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